POOJA LAWANSHI’s Post

BIO-RESEARCH: Emcure Pharmaceuticals Limited has announced the inauguration of its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. Click to read: https://lnkd.in/gvwm_kmD #researchanddevelopment #rnd #biopharma #pharma #biovoicenews

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐇𝐨𝐭 𝐌𝐞𝐥𝐭 𝐄𝐱𝐭𝐫𝐮𝐬𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀 𝐆𝐚𝐦𝐞-𝐂𝐡𝐚𝐧𝐠𝐞𝐫 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲! 𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐟𝐨: https://lnkd.in/eYsryPGM The Pharmaceutical Hot Melt Extrusion (HME) market is rapidly gaining momentum as an innovative technology reshaping drug formulation and delivery. 𝐖𝐡𝐲 𝐢𝐬 𝐇𝐌𝐄 𝐌𝐚𝐤𝐢𝐧𝐠 𝐖𝐚𝐯𝐞𝐬? Enhanced Bioavailability: HME improves the solubility and bioavailability of poorly soluble drugs, ensuring more effective treatments. Versatility: From sustained-release formulations to taste masking, HME offers a wide range of applications, making it a versatile solution for complex drug formulations. Continuous Processing: With the shift towards continuous manufacturing, HME stands out for its efficiency, scalability, and consistency in producing high-quality pharmaceuticals. As the demand for novel drug delivery systems continues to rise, the HME market is set to experience significant growth. Companies that invest in this technology today will be at the forefront of the next generation of pharmaceutical innovation. #PharmaceuticalIndustry #HotMeltExtrusion #DrugDelivery #Innovation #PharmaTech #Healthcare

Achieving a stable emulsion can be challenging in pharmaceutical and cosmetic formulations. An emulsion is a mixture of two liquids that generally do not mix well, such as oil and water. Goma's Emulsion Plants use advanced homogenization techniques to create uniform emulsions with consistent droplet sizes and stability. This is essential for applications such as drug delivery systems, creams, lotions, and more. Website: https://goma.co.in/ #Goma #GomaEngineering #EmulsionPlant #Homogenization #Pharmaceutical #CosmeticIndustry #AdvancedPlant #Cream #Lotions

For #drug developers working on oral solid dosage drug projects, #solubility, and therefore #bioavailability is a significant challenge. Solubility is inherently linked to bioavailability, and therefore, must be addressed first. If a drug cannot be dissolved through the #gastrointestinal (GI) tract into the bloodstream – due to poor solubility – it will not reach systemic circulation and ultimately lead to low bioavailability. At present, poor water solubility impacts around 40% of drugs currently in the market. While in the developmental pipeline, up to 90% of potential active pharmaceutical ingredients (APIs) or new chemical entities (NCEs) are poorly soluble and cannot form viable drug products. In the industry, they are often known as brick-dust APIs. #Class II and IV drugs (APIs) exhibit poor #solubility, lower #bioavailability, and less #dissolution. For this reason, Sigachi Pharma has developed new excipients providing an opportunity to extend the functionality of current solubility-enhancing. Thanks to Sigachi Pharma for developing the #BARETab®SL it is becoming easier for drug developers to overcome solubility issues during the early stages of development and formulation. From the emergence of #novel excipients to the increasing acceptance of solid dispersion techniques, formulators have new solutions to add to their toolbox.

Salt does more than you think in pharmaceuticals! From improving stability and solubility to enhancing drug release, sodium chloride is a powerhouse in drug formulation. 🌡️✨ #PharmaScience #DrugFormulation #SaltInMedicine #PharmaceuticalInnovation #HealthTech #Bioavailability #MedicineMatters #PharmaEssentials #medicalscience #pakminerals

𝐓𝐡𝐞 𝐑𝐨𝐥𝐞 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐄𝐱𝐜𝐢𝐩𝐢𝐞𝐧𝐭𝐬: 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐧𝐠 𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 & 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 Pharmaceutical excipients may not be the active ingredient, but they are essential in ensuring the effectiveness, stability, and safety of drug formulations. From improving solubility to enhancing drug release profiles, excipients play a critical role in drug efficacy and patient compliance. 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/dR5ESZSx 📈 Market Growth & Outlook The global Pharmaceutical Excipients Market is poised for significant growth, with analysts predicting a CAGR of 6.02% from 2024 to 2031. This growth is driven by the increasing demand for innovative drug delivery systems, the rise of biologics, and the need for excipients that enhance bioavailability. In particular, the shift toward oral solid dosage forms and the development of sustained-release formulations are fueling the demand for multifunctional excipients. Moreover, regulatory advancements and partnerships between pharmaceutical companies and excipient manufacturers are unlocking new opportunities, particularly in emerging markets. 🔬 Key Innovations: Nanoparticle-based excipients for targeted delivery Biodegradable polymers for sustained release Natural and plant-based excipients for improved biocompatibility Major Players Ashland, Roquette, Evonik, IFF, BASF, Kerry, Associated British Foods plc, Merck KGaA, Darmstadt, Germany, WACKER and ADM #PharmaceuticalExcipients #ExcipientInnovation #DrugDeliverySolutions #PharmaFormulations #HealthcareInnovation #PharmaIndustry #DrugDevelopment #PharmaTech #LifeSciences #BASF #Evonik #DuPont #Colorcon #Ashland #PharmaLeaders #ExcipientsMarket

🌟 New Launch: 1A10400-Metronidazole Acid by Analytica Chemie Inc. 🌟 We are excited to introduce 1A10400-Metronidazole Acid, a premium analytical #reference standard now available from Analytica Chemie Inc. (ACI), with global #distribution through #USP. This product reinforces our dedication to advancing #pharmaceutical #quality and #innovation with trusted, high-purity solutions for research and development. ✅ Key Features of ACI’s 1A10400-Metronidazole Acid: #Manufactured under stringent #quality control for superior accuracy Suitable for analytical applications and #pharmaceutical #formulation development Distributed by USP for worldwide accessibility and dependable supply At ACI, we continue to drive excellence in pharmaceutical #science by offering precise, reliable #products that meet evolving #industry demands. 📩 Contact ACI today to learn more about 1A10400-Metronidazole Acid and its applications! https://lnkd.in/g-d8Sf5q #MetronidazoleAcid #PharmaInnovation #ACILaunch #USPCollaboration #AnalyticalStandards #PharmaceuticalExcellence

🔬 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆: 𝗗𝗲𝘁𝗲𝗰𝘁𝗶𝗻𝗴 𝗦𝗮𝗹𝗺𝗼𝗻𝗲𝗹𝗹𝗮 𝘀𝗽𝗽. 𝘄𝗶𝘁𝗵 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 🔬 In pharmaceutical manufacturing, ensuring product safety is paramount. Our advanced methods for 𝗦𝗮𝗹𝗺𝗼𝗻𝗲𝗹𝗹𝗮 𝘀𝗽𝗽. 𝗱𝗲𝘁𝗲𝗰𝘁𝗶𝗼𝗻 provide accurate, reliable results to safeguard your processes and meet industry standards. 🧬 𝗦𝘁𝗲𝗽 𝗜: 𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗘𝗻𝗿𝗶𝗰𝗵𝗺𝗲𝗻𝘁 1️⃣ Enrich using Trypticasein Soy Broth and Rappaport Vassidialis Broth. 2️⃣ Incubate at 30-35ºC for 18-24 hours. 🧬 𝗦𝘁𝗲𝗽 𝗜𝗜: 𝗦𝗲𝗹𝗲𝗰𝘁𝗶𝘃𝗲 𝗜𝘀𝗼𝗹𝗮𝘁𝗶𝗼𝗻 3️⃣ Subculture on XLD Agar. 4️⃣ Incubate at 30-35ºC for 18-48 hours. 🧬 𝗦𝘁𝗲𝗽 𝗜𝗜𝗜: 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝗮𝘁𝗶𝗼𝗻 5️⃣ Identify red colonies (with/without black nucleus) using advanced identification tests to confirm Salmonella spp. 🔍 These steps ensure the pharmaceutical industry maintains stringent quality control, protecting both patients and products. 🔬 𝗥𝗲𝗰𝗮𝗽: 𝗠𝗶𝗰𝗿𝗼𝗯𝗶𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗙𝗼𝗼𝗱 𝗦𝗮𝗳𝗲𝘁𝘆 🔬 Step I: https://lnkd.in/gFsrGSBp Step II & III: https://lnkd.in/gvwHFdJS For inquiries, contact us at sales@biomediaholdings.com or visit our website at biomediaholdings.com. #Microbiology #Pharmaceutical #Safety #Salmonella #QualityControl #Pathogen #Detection #Pharma #Tech #Innovation #GlobalHealth

ETHYL 2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-5-THIAZOLECARBOXYLATE is synthesized for various purposes, including pharmaceuticals or agrochemicals. End Use API : FEBUXOSTAT The compound's structure suggests potential applications in drug development or as a precursor for the synthesis of other compounds due to its unique molecular properties. Make your purchase earliest at affordable price range.   Product name : ETHYL 2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-5-THIAZOLECARBOXYLATE CAS                : 160844-75-7 READILY AVAILABLE , READY TO SERVE YOU BETTER QUALITY.   All inquiries are welcomed.   SHARE YOUR REQUIREMENTS WITH US ON : sales@dolphinpharma.com   Contact no: +91 261 2345778 / +91 99250 17711 (WhatsApp) Skype : DOLPHINEPHARMA   #intermediates #160844757 #activepharmaceuticalingredients #febuxostat #apimanufacturing  #GAUT #formulation #dolphinpharmaceutical #pharmaceutical #specialitychemicals #pharmaceuticalmanufacturing  #finechemicals #dolphinpharma #pharmaindustry #drugdevelopment #exporter #apiexporter 

The Global #Urinalysis Market Size is Anticipated to Exceed USD 6.76 Billion by 2033, Growing at a CAGR of 5.41% from 2023 to 2033. Read More: https://lnkd.in/gna3nBk3 #medical #healthcare #biotechnology #laboratory #testing #statistics #report #marketstudy #pharmaceutical #sphericalinsights